deltatrials
Completed PHASE1 NCT00065663

Gene Therapy to Improve Wound Healing in Patients With Diabetes

Growth Factor Gene Therapy for Wound Healing

Sponsor: Tissue Repair Company

Conditions Diabetes Diabetic Foot Ulcers Foot Wounds Wounds and Injuries
Interventions GAM501
Updated 5 times since 2017 Last updated: Nov 16, 2007 Started: Aug 31, 2002 Completion: Dec 31, 2004

Listed as NCT00065663, this PHASE1 trial focuses on Diabetes and Diabetic Foot Ulcers and remains completed. Sponsored by Tissue Repair Company, it has been updated 5 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Aug 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Tissue Repair Company
Data source: Tissue Repair Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Phoenix, United States
  • • San Diego, United States